Documents/HHSFACA852/1: Recommandations/1: Make, Accept, Implement/Indicator:1

Indicator: 1

[Output]

Measurements in/of Recommendations Made

Relationships:

Department of Health and Human Services - Narrower_Than

Other Information:

Center for Substance Abuse Prevention Drug Testing Advisory Board

Type Target Actual
StartDate 2010-10-01 2010-10-01
EndDate 2011-09-30 2011-09-30
Number n/a 37
Description Unspecified From FY 1994 to FY 2010, the CSAP DTAB produced 35 recommendations. In FY 2011, the CSAP DTAB submitted two recommendations to the SAMHSA Administrator.Recommendation 1.Based on review of the science, DTAB recommends that SAMHSA include oral fluid as an alternative specimen in the Mandatory Guidelines for Federal Workplace Drug Testing Programs.Recommendation 2.DTAB recommends the inclusion of additional Schedule II prescription medications (e.g., oxycodone, oxymorphone, hydrocodone and hydromorphone) in the Mandatory Guidelines for Federal Workplace Drug Testing Programs.

Content